NEW YORK, Aug. 13, 2025 /PRNewswire/
The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2025 Prix Galien USA Award nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup.” Winners will be announced during the Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.
“As Jury Chair, I am honored to recognize these exceptional nominees who exemplify the transformative power of innovation in medical technology, digital health, and entrepreneurship,” said Kenneth C. Frazier, Chair of the Jury, Prix Galien USA Awards Committee. “Their groundbreaking work represents the future of healthcare and our shared commitment to improving lives through scientific excellence.”
The 2025 Prix Galien USA nominees include products from the following categories: “Best Digital Health Solution” – 25 nominees; “Best Medical Technology” – 25 nominees; “Best Incubators, Accelerators and Equity” – 12 nominees, and “Best Startup” – 53 nominees.
To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for marketing within the last five years and demonstrate tremendous potential to improve human health. Sales data are not considered by the nominating committee in their award nominee selection, only science and health impact.
Best Startup (Nominees)
Actipulse Neuroscience Actipulse
[….]
REGEnLIFE
[….]
Zest Health Zest Health
Best Digital Health Solution (Nominees)
Abbott NeuroSphere™ Virtual Clinic
[….]
Wheel Wheel Horizon
Best Medical Technology (Nominees)
Abbott Esprit™ BTK Everolimus Eluting Resorbable Scaffold System
[….]
Terumo Aortic Thoraflex Hybrid
Best Incubators, Accelerators and Equity (Nominees)
AVANT BIO AVANT BIO Fund II LP
[….]
OROT – CIUSSS West-Central Montreal OROT – Connected Health Incubator, CIUSSS West Central (Montréal)
Bruno Cohen, Chairman of The Galien Foundation, commented, “We are honored to recognize this year’s outstanding Prix Galien USA nominees, whose innovation in medical technology, digital health, and entrepreneurship demonstrates the progress that moves healthcare forward. Their achievements reveal the extraordinary potential of science to change life.”
Prix Galien Best Medical Technology, Best Digital Health Solution, Best Incubator / Accelerator / Equity, and Best Startup Committee 2025
Kenneth C. FRAZIER
Committee Chair, Former Chairman & CEO Merck
Roch DOLIVEUX
Honorary CEO, UCB
Dr. Mikael DOLSTEN
Chief Scientific Officer & President, Pfizer Research and Development
Alex GORSKY
Former CEO & Executive Chairman, Johnson & Johnson
Penny HEATON
Global Therapeutic Area Head, Vaccines, Janssen
Sheri McCOY
Board of Directors, AstraZeneca, Former CEO, Avon
Joel S. MARCUS
Executive Chairman & Founder, Alexandria
Elias ZERHOUNI
Former Head of Global R&D, Sanofi
About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation
